Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleCost-Effectiveness of Lenvatinib Compared with Sorafenib for the First-Line Treatment of Advanced Hepatocellular Carcinoma in Australia.AuthorsSaiyed, Masnoon; Byrnes, Joshua; Srivastava, Tushar; Scuffham, Paul; Downes, MartinPublicationClinical Drug Investigation, 2020, Vol 40, Issue 12, p1167ISSN1173-2563Publication typeArticleDOI10.1007/s40261-020-00983-7